Le Lézard
Classified in: Health
Subjects: PER, MAT

ACFS Announces the Arrival of Dr. Evan Reshef as a New Member of its Fertility Team


Dr. Evan Reshef Joins ACFS as Fertility Specialist, Enhancing Patient Care and Services.

PHOENIX, Dec. 19, 2023 /PRNewswire-PRWeb/ -- Arizona Center for Fertility Studies (ACFS) is pleased to announce that Dr. Evan Reshef has joined its team of fertility specialists. With his background in Reproductive Endocrinology and Infertility, Dr. Reshef returns to Arizona, bringing valuable experience to the center.

"Dr. Reshef's arrival marks an exciting time for us at ACFS," said Shane Lipskind, MD. "His expertise in reproductive medicine and his approach to patient care are great assets to our team."

After completing his fellowship at Columbia University, Dr. Reshef has gained considerable experience in the field. His focus on compassionate care aligns with ACFS's commitment to helping individuals and couples on their fertility journey. "I am dedicated to providing thoughtful care and supporting our patients at ACFS," said Dr. Reshef.

ACFS, known for its personalized fertility treatments, welcomes Dr. Reshef as part of its ongoing effort to enhance its services.

"We believe Dr. Reshef will make a significant contribution to our practice and more importantly, to the families we assist," added Lipskind.

To schedule a consultation with Dr. Reshef, patients can contact ACFS at (480) 860-4792. For more details about ACFS's services, please visit www.acfs2000.com

About ACFS

Arizona Center for Fertility Studies, with its dedicated team of fertility specialists and multiple locations in the Phoenix area, is focused on helping patients to achieve their dreams of parenthood.

Contact:

ACFS Fertility

(480) 860-4792

8426 E Shea Blvd.

Scottsdale, AZ 85260

SOURCE ACFS Fertility


These press releases may also interest you

at 05:30
Spanios, a firm that created and leverages its unique 3D tumoroid platforms to validate solid tumor therapies today announced a partnership with Accelerated Biosciences, a company that licenses its commercial-grade human trophoblast stem cell (hTSC)...

at 05:00
A VIP Party and Ribbon-Cutting Ceremony was held for Green Oaks of Valparaiso, a new affordable assisted lifestyle community for older adults is now...

at 04:00
The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, today announced the 2024 Prix Galien UK Award candidates for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical...

at 04:00
Globally, cardiovascular diseases due to atherosclerosis ? the build-up of plaque in arteries ? are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and...

at 03:33
Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, has received confirmation of an extension of its contract with The Norwegian Hospital Procurement Trust (Sykehusinnkjøp HF)...

at 03:00
One in four people with pre-existing medical conditions (25%) say they will not declare all of their medical conditions when buying travel insurance, with 40% of these only declaring what they are currently being treated for. Of those that would not...



News published on and distributed by: